BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28620836)

  • 1. SOX2 immunity and tissue resident memory in children and young adults with glioma.
    Vasquez JC; Huttner A; Zhang L; Marks A; Chan A; Baehring JM; Kahle KT; Dhodapkar KM
    J Neurooncol; 2017 Aug; 134(1):41-53. PubMed ID: 28620836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of PD-L1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas.
    Jha P; Manjunath N; Singh J; Mani K; Garg A; Kaur K; Sharma MC; Raheja A; Suri A; Sarkar C; Suri V
    Neuropathology; 2019 Dec; 39(6):413-424. PubMed ID: 31625205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis.
    Zhang L; Zhang B; Dou Z; Wu J; Iranmanesh Y; Jiang B; Sun C; Zhang J
    Front Immunol; 2021; 12():582594. PubMed ID: 33815356
    [No Abstract]   [Full Text] [Related]  

  • 4. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma.
    Robinson MH; Vasquez J; Kaushal A; MacDonald TJ; Velázquez Vega JE; Schniederjan M; Dhodapkar K
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.
    Hwang K; Koh EJ; Choi EJ; Kang TH; Han JH; Choe G; Park SH; Yearley JH; Annamalai L; Blumenschein W; Sathe M; McClanahan T; Jung H; Wang KC; Kim SK; Kim CY
    J Neurooncol; 2018 Sep; 139(2):281-291. PubMed ID: 29730815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
    Garber ST; Hashimoto Y; Weathers SP; Xiu J; Gatalica Z; Verhaak RG; Zhou S; Fuller GN; Khasraw M; de Groot J; Reddy SK; Spetzler D; Heimberger AB
    Neuro Oncol; 2016 Oct; 18(10):1357-66. PubMed ID: 27370400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.
    Schmitz M; Temme A; Senner V; Ebner R; Schwind S; Stevanovic S; Wehner R; Schackert G; Schackert HK; Fussel M; Bachmann M; Rieber EP; Weigle B
    Br J Cancer; 2007 Apr; 96(8):1293-301. PubMed ID: 17375044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial TIM-3 Modulates Immune Responses in the Brain Tumor Microenvironment.
    Kim HS; Chang CY; Yoon HJ; Kim KS; Koh HS; Kim SS; Lee SJ; Kane LP; Park EJ
    Cancer Res; 2020 May; 80(9):1833-1845. PubMed ID: 32094297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
    Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
    Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
    Wei J; Nduom EK; Kong LY; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C; Fuller GN; Gilbert MR; Overwijk W; Calin GA; Heimberger AB
    Neuro Oncol; 2016 May; 18(5):639-48. PubMed ID: 26658052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.
    Plant AS; Koyama S; Sinai C; Solomon IH; Griffin GK; Ligon KL; Bandopadhayay P; Betensky R; Emerson R; Dranoff G; Kieran MW; Ritz J
    J Neurooncol; 2018 Apr; 137(2):269-278. PubMed ID: 29322427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty Acid Oxidation Controls CD8
    Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
    Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
    Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
    Front Immunol; 2019; 10():2430. PubMed ID: 31681314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.